The mission of the Sidney Kimmel Cancer Center MetaOmics Shared Resource (MOSR) is to provide a comprehensive resource across the SKCC consortium that meets all the ?omics? needs of SKCC members through a single portal. These ?omics? include: genomics, epigenetics, transcriptomics, proteomics, glycomics, metabolomics, and lipidomics. The MOSR evolved during the last project period through a carefully planned expansion of the SKCC?s former Cancer Genomics Shared Resource (CGSR). The CGSR, founded in 2007 by Paolo Fortina, MD, PhD, fostered leading-edge cancer research through its technology and specialized expertise in genomics and bioinformatics. In response to growing demand for a broader range of omics capabilities, the CGSR combined with a developing facility at Drexel University College of Medicine, led by Garth Ehrlich, PhD, FAAAS. Dr. Ehrlich now serves as the MOSR Director, and Dr. Fortina serves as Co- Director of the combined facility. New or enhanced services include: consultative faculty-level experimental design services; state-of-the-art laboratory services covering multiple omics disciplines; and data analysis services for high throughput and high fidelity omics-based technologies provided by a team of highly trained bioinformaticians. Besides new instrumentation platforms, the MOSR continues to provide Illumina-based high- throughput short-read DNA sequencing and RNAseq capabilities, as well as array-based technologies. Current goals for the MOSR include: 1) Leverage the latest genomics, proteomics, and metabolomics technologies to serve SKCC members conducting advanced cancer research; 2) Provide expertise and guidance in experimental and project design and analysis through a single portal; 3) Promote a user friendly environment by providing expert consultations, high-quality services at reasonable fees, fast turnaround, and ready access to equipment after training; 4) Provide bioinformatics analysis on all samples ensuring rapid feedback on sample and library quality, suggest future experiments indicating whether additional analyses are warranted; 5) Coordinate with other SKCC Shared Resources, particularly Biostatistics, Translational Pathology, and Flow Cytometry, to efficiently and effectively support larger-scale projects on behalf of all users.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA056036-19
Application #
9492090
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
19
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469

Showing the most recent 10 out of 807 publications